methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet
- RxCUI
- 1926849
- RxNorm name
- methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet
- Display name
- methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet
- Full name
- methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Extended-Release | METHYLPHENIDATE EXTENDED-RELEASE | Neos Therapeutics, LP | c2fec19b-6610-4ce0-8e60-f8218a11f62f | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 1926849 |
| Cotempla XR-ODT | METHYLPHENIDATE | Neos Therapeutics Brands, LLC | 33f70f58-c871-42c8-8adb-345caeafefcd | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | 1926849 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 33f70f58-c871-42c8-8adb-345caeafefcd | methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | 20250924 |
| 33f70f58-c871-42c8-8adb-345caeafefcd | methylphenidate 25.9 MG Disintegrating Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | 20250924 |